This period emphasizes large-scale, industrial-style screening of natural product libraries and fermentation-driven production to deliver clinically useful compounds. Collaboration between discovery programs and production pipelines accelerated translation from initial finds to therapies. The approach increasingly focused on microbial metabolite exploration, chemical diversification, and early genetic understandings of antibiotic action, shaping a postwar drug-discovery paradigm.